Repligen Corp. (RGEN)
162.05
+0.03
(+0.02%)
USD |
NASDAQ |
Jan 20, 11:02
Repligen EPS Diluted (Quarterly): 0.2638 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Enovis Corp. | -9.990 |
| Perspective Therapeutics, Inc. | -0.3495 |
| InfuSystem Holdings, Inc. | 0.1078 |
| Xtant Medical Holdings, Inc. | 0.0087 |
| VolitionRX Ltd. | -0.0497 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 14.91M |
| Revenue (Quarterly) | 188.80M |
| Total Expenses (Quarterly) | 173.89M |
| Enterprise Value | 9.060B |
| Gross Profit Margin (Quarterly) | 47.99% |
| Profit Margin (Quarterly) | 7.90% |
| Earnings Yield | 0.02% |
| Operating Earnings Yield | 0.51% |
| Normalized Earnings Yield | 0.3705 |